Ayala Pharmaceuticals Gross margin
What is the Gross margin of Ayala Pharmaceuticals?
The Gross margin of Ayala Pharmaceuticals Inc. is 100.00%
What is the definition of Gross margin?
Gross margin is the difference between revenue and cost of goods sold, divided by revenue, and expressed as a percentage.
lfy (last fiscal year)
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Gross margin of companies in the Health Care sector on NASDAQ compared to Ayala Pharmaceuticals
What does Ayala Pharmaceuticals do?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Companies with gross margin similar to Ayala Pharmaceuticals
- Zenkoku Hosho Co has Gross margin of 99.99%
- Damartex SA has Gross margin of 100.00%
- Consolidated Finvest & has Gross margin of 100.00%
- McDowell has Gross margin of 100.00%
- Vanguard Specialized Funds - Vanguard Real Estate ETF has Gross margin of 100.00%
- BlackRock MuniVest Fund has Gross margin of 100.00%
- Ayala Pharmaceuticals has Gross margin of 100.00%
- CRCAM Loire Haute-Loire has Gross margin of 100.00%
- iShares Trust - iShares Core S&P 500 ETF has Gross margin of 100.00%
- Clean Power Capital has Gross margin of 100.00%
- Investec plc has Gross margin of 100.00%
- Atlas Mara has Gross margin of 100.00%
- Huarong International has Gross margin of 100.00%